Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in SPRB — Spruce Biosciences, Inc.

CIK 1214717 BOSTON, MA
Back to SPRB Full portfolio

Position in SPRB

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,809,592
+$2,967,297 QoQ
Shares Held
70,548
+447.4% QoQ
Ownership
2.45%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 63 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. SPRB ranks #266 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in SPRB

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,809,592 70,548
2026-03-31 $842,295 12,889
2025-12-31 $1,109,083 12,732
2025-03-31 $80,244 276,708
2024-12-31 $114,989 273,785
2024-09-30 $124,424 261,948
2024-06-30 $105,672 204,002
2024-03-31 $157,327 200,162
2023-12-31 $490,493 167,404
2023-09-30 $378,333 167,404
2023-06-30 $468,508 217,911
2023-03-31 $133,972 60,621
2022-12-31 $66,501 60,621
2022-09-30 $83,234 60,755
2022-06-30 $105,713 60,755
2022-03-31 $255,326 127,028
2021-12-31 $635,411 142,469
2021-09-30 $669,616 111,417
2021-06-30 $1,441,000 128,546
2021-03-31 $1,818,480 109,547
2020-12-31 $2,856,862 117,518